Insulin Detemir Results in Less Weight Gain than NPH Insulin When??Used in Basal-Bolus Therapy for??Type??2 Diabetes??Mellitus, and this??Advantage Increases with Baseline??Body??Mass Index

2007 ◽  
Vol 27 (4) ◽  
pp. 279-285 ◽  
Author(s):  
Katarina Ra??lov?? ◽  
Soren Can Tamer ◽  
Per Clauson ◽  
Diane Karl
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Type 2 Diabetes Mellitus ◽  
Weight Gain ◽  
Insulin Detemir ◽  
Baseline Body Mass Index ◽  
Nph Insulin ◽  
Basal Bolus

Efficacy of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) by Baseline Body Mass Index (BMI)

2014 ◽  
Vol 38 (5) ◽  
pp. S45-S46
Author(s):  
Lawrence A. Leiter ◽  
Lawrence Blonde ◽  
John Wilding ◽  
Sonia Cerdas ◽  
Cindy Tong ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Type 2 Diabetes Mellitus ◽  
Body Mass ◽  
Baseline Body Mass Index

scholarly journals Type 2 Diabetes Mellitus Management and Body Mass Index: Experiences with Initiating Insulin Detemir in the A1chieve Study

2014 ◽  
Vol 5 (1) ◽  
pp. 127-140 ◽  
Author(s):  
Mohammed E. Khamseh ◽  
Vinay Prusty ◽  
Zafar Latif ◽  
Guillermo Gonzalez-Galvez ◽  
Guillermo Dieuzeide ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Type 2 Diabetes Mellitus ◽  
Body Mass ◽  
Insulin Detemir ◽  
Diabetes Mellitus Management

Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis

2009 ◽  
Vol 25 (5) ◽  
pp. 1273-1284 ◽  
Author(s):  
Sandra L. Tunis ◽  
Michael E. Minshall ◽  
Christopher Conner ◽  
John I. McCormick ◽  
Jovana Kapor ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Insulin Detemir ◽  
Nph Insulin ◽  
Modeling Analysis
Sign in / Sign up

Export Citation Format

Share Document